Wed, August 3, 2011
Tue, August 2, 2011
Mon, August 1, 2011
Sun, July 31, 2011
Fri, July 29, 2011
Thu, July 28, 2011
Wed, July 27, 2011
[ Wed, Jul 27th 2011 ] - Market Wire
00 AM EDT
Tue, July 26, 2011
Mon, July 25, 2011
Sat, July 23, 2011
Fri, July 22, 2011
Thu, July 21, 2011
Wed, July 20, 2011
[ Wed, Jul 20th 2011 ] - Market Wire
Pfizer To Acquire Icagen
[ Wed, Jul 20th 2011 ] - Market Wire
00 a.m. EDT
Tue, July 19, 2011
Mon, July 18, 2011
[ Mon, Jul 18th 2011 ] - Market Wire
Aetna to Acquire PayFlex
Fri, July 15, 2011
Thu, July 14, 2011
Wed, July 13, 2011
Tue, July 12, 2011
Mon, July 11, 2011
Sun, July 10, 2011
Sat, July 9, 2011
Fri, July 8, 2011

The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Allos Therapeutics, Inc.


//health-fitness.news-articles.net/content/2011/ .. ces-investigation-of-allos-therapeutics-inc.html
Published in Health and Fitness on Wednesday, July 20th 2011 at 9:51 GMT by Market Wire   Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Allos Therapeutics, Inc. (aAllosa or the aCompanya) (NASDAQ: ALTH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AMAG Pharmaceuticals, Inc. (aAMAGa) (NASDAQ: AMAG). Under the terms of the transaction, Allos stockholders will receive a fixed ratio of 0.1282 shares of AMAG stock for each share of Allos common stock they own, representing a value of approximately $2.44 a share. The transaction has a total approximate value of $686 million.

Click here to learn how to join the action: [ http://www.zlk.com/allos-therapeutics-alth ], or call: 877-363-5972.

The investigation concerns whether the Allos Board breached its fiduciary duties to stockholders by failing to adequately shop the Company before entering into this deal and whether AMAG is underpaying for Allos shares, thus unlawfully harming Allos stockholders. In particular, Allos stock has traded as high as $4.15 as recently as January 12, 2011. Furthermore, at least one analyst set a price target of $8.00 per Allos share.

If you own common stock in Allos and wish to obtain additional information, please contact Joseph Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com ].

Levi & Korsinsky is a national firm with offices in New York, California and Washington D.C. The firm has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions and have a combined experience of more than 50 years. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
Joseph Levi, Esq.
30 Broad Street - 15th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
[ www.zlk.com ]


Publication Contributing Sources